Treatment
IPN10200 clinical trials
We’re tracking 5 recruiting studies that include IPN10200, each written for real people, not researchers, below.
Recruiting studies
- NCT06937931RecruitingPhase 2
Study of IPN10200 for neck muscle spasms in adults
This trial tests a new botulinum toxin medication (IPN10200) for adults with cervical dystonia, a condition that causes painful muscle spasms in the neck and shoulders. It aims to see if the treatment is safe and effective in reducing symptoms.
Tucson, ArizonaAges 18–80 - NCT06625060RecruitingPhase 2
Study of IPN10200 for preventing migraine in adults
This trial tests a new medicine called IPN10200 to see if it can prevent episodic or chronic migraine. It is for adults who have had migraine for at least a year and have tried at least one preventive treatment before.
Birmingham, AlabamaAges 18–80 - NCT07427797RecruitingPhase 3
Study of a treatment for frown lines between the eyebrows
This study tests a new medicine (IPN10200) to see how well it works and how safe it is for reducing moderate to severe frown lines between the eyebrows in adults. If you are unhappy with the appearance of these lines, this trial may help.
Birmingham, AlabamaAges 18–80 - NCT07435428RecruitingPhase 3
Study of a new treatment for moderate to severe frown lines between eyebrows
This trial tests a new medication's effectiveness and safety over time in adults with moderate to severe frown lines between the eyebrows. It aims to see if the treatment can reduce these lines and improve satisfaction with appearance.
Los Angeles, CaliforniaAges 18–80 - NCT04752774RecruitingPhase 1/Phase 2
Botox-like injection study for arm spasticity after stroke
This trial tests whether IPN10200, a Botox-like treatment, is safe and helps reduce stiff, tight upper-arm muscles caused by spasticity after stroke or brain injury. You may be able to join if you meet specific timing, prior-treatment, and muscle-stiffness measurements.
Downey, CaliforniaAges 18–70
What IPN10200 is being studied for
Conditions with recruiting IPN10200 studies.
Common questions
- Are there clinical trials studying IPN10200?
- Yes. Clin2 currently lists 5 recruiting studies that include IPN10200, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a IPN10200 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is IPN10200 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether IPN10200 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.